A Clinical Study of BT02 in Treating Patients With Advanced Lung Cancer

Clinical trial NCT07110363 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07110363
Sponsor: Biotroy Therapeutics
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignant Solid Tumor Advanced Lung Cancer Non-Small Cell Lung Cancer Small Cell Lung Cancer

Start date: 2025-08-01
Primary completion: 2027-03-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.